Polyclonal Antibody to Breast Carcinoma Amplified Sequence 2 (BCAS2)

DAM1; SPF27; Pre-mRNA-Splicing Factor SPF27; DNA amplified in mammary carcinoma 1 protein; Spliceosome-associated protein SPF 27

  • Polyclonal Antibody to Breast Carcinoma Amplified Sequence 2 (BCAS2) Packages (Simulation)
  • Polyclonal Antibody to Breast Carcinoma Amplified Sequence 2 (BCAS2) Packages (Simulation)
  • Certificate ISO9001: 2008, ISO13485: 2003 Registered

SPECIFITY of the Polyclonal Antibody to Breast Carcinoma Amplified Sequence 2 (BCAS2)

The antibody is a rabbit polyclonal antibody raised against BCAS2. It has been selected for its ability to recognize BCAS2 in immunohistochemical staining and western blotting.

USAGE of the Polyclonal Antibody to Breast Carcinoma Amplified Sequence 2 (BCAS2)

Western blotting: 0.01-2µg/mL;
Immunohistochemistry: 5-20µg/mL;
Immunocytochemistry: 5-20µg/mL;
Optimal working dilutions must be determined by end user.

STORAGE of the of the Polyclonal Antibody to Breast Carcinoma Amplified Sequence 2 (BCAS2)

Store at 4°C for frequent use. Stored at -20°C in a manual defrost freezer for two year without detectable loss of activity. Avoid repeated freeze-thaw cycles.

STABILITY of the Polyclonal Antibody to Breast Carcinoma Amplified Sequence 2 (BCAS2)

The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

GIVEAWAYS

Related products

Catalog No. Organism species: Homo sapiens (Human) Applications (RESEARCH USE ONLY!)
RPF222Hu01 Recombinant Breast Carcinoma Amplified Sequence 2 (BCAS2) Positive Control; Immunogen; SDS-PAGE; WB.
PAF222Hu01 Polyclonal Antibody to Breast Carcinoma Amplified Sequence 2 (BCAS2) WB; IHC; ICC; IP.
GUESTBOOK